Prof. Dr. med. Ulrich Germing

Prof. Dr. med. Ulrich Germing is a highly experienced doctor specializing in internal medicine, hematology, and oncology. With over 31 years of experience, he is currently the Acting Director of the Department of Hematology, Oncology, and Clinical Immunology at the University Hospital Dusseldorf in Germany. One of the most intriguing aspects of Dr. Germing's career is his involvement in various research projects and clinical committees. He has been a member of the working group of myelodysplastic syndromes since 1989 and the WHO clinical advisory committee on the classification of myeloid and lymphoid malignant neoplasms since 2007. These roles demonstrate his expertise and dedication to advancing the field of hematology and oncology. Furthermore, Dr. Germing has an impressive list of 685 scientific publications, highlighting his contributions and involvement in cutting-edge research. His publications cover various topics, including immunomodulatory drugs in cancer treatment, prognostic factors in myelodysplastic syndromes, and the impact of genetic mutations on treatment outcomes. This demonstrates his commitment to staying at the forefront of medical knowledge and finding innovative approaches to patient care. Overall, Prof. Dr. med. Ulrich Germing's extensive experience, involvement in research, and dedication to advancing the field of hematology and oncology make him a highly respected and skilled doctor. Patients can trust in his expertise and benefit from the knowledge he brings to his practice at the University Hospital Dusseldorf.